Betrixaban-d6

• Description :

  Betrixaban-d6 is a deuterium labeled Betrixaban. Betrixaban is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor[1].

• Product Name Alternative :

  PRT054021-d6

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H373

• Target :

  Factor Xa

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease

• Purity :

  99.02

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(C1=CC=C(C=C1)C(N(C([2H])([2H])[2H])C([2H])([2H])[2H])=N)NC2=C(C=C(C=C2)OC)C(NC3=CC=C(C=N3)Cl)=O

• Molecular Formula :

  C23H16D6ClN5O3

• Molecular Weight :

  457.94

• Precautions :

  H302, H373

• References & Citations :

  [1]Zhang P, et al. Discovery of Betrixaban (PRT054021), N- (5-chloropyridin-2-yl) -2- (4- (N, N-dimethylcarbamimidoyl) benzamido) -5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor. Bioorg Med Chem Lett. 2009 Apr 15;19 (8) :21.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• CAS Number :

  [2098655-51-5]